La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Green Cross Medical Science Bilan de santé
Santé financière contrôle des critères 3/6
Green Cross Medical Science has a total shareholder equity of ₩38.3B and total debt of ₩23.8B, which brings its debt-to-equity ratio to 62.2%. Its total assets and total liabilities are ₩96.2B and ₩57.9B respectively. Green Cross Medical Science's EBIT is ₩191.3M making its interest coverage ratio 0.1. It has cash and short-term investments of ₩11.9B.
Informations clés
62.2%
Ratio d'endettement
₩23.81b
Dette
| Ratio de couverture des intérêts | 0.06x |
| Argent liquide | ₩11.85b |
| Fonds propres | ₩38.30b |
| Total du passif | ₩57.95b |
| Total des actifs | ₩96.25b |
Mises à jour récentes de la santé financière
Recent updates
There's No Escaping Green Cross Medical Science Corporation's (KOSDAQ:142280) Muted Revenues Despite A 45% Share Price Rise
Aug 08
We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated
Mar 26Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings
Mar 23These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively
Feb 24Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?
Jan 28Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?
Jan 02Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?
Dec 07Analyse de la situation financière
Passif à court terme: A142280's short term assets (₩49.4B) do not cover its short term liabilities (₩50.8B).
Passif à long terme: A142280's short term assets (₩49.4B) exceed its long term liabilities (₩7.1B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: A142280's net debt to equity ratio (31.2%) is considered satisfactory.
Réduire la dette: A142280's debt to equity ratio has reduced from 149.8% to 62.2% over the past 5 years.
Couverture de la dette: A142280's debt is not well covered by operating cash flow (13.5%).
Couverture des intérêts: A142280's interest payments on its debt are not well covered by EBIT (0.1x coverage).